NCT00546520View on ClinicalTrials.gov

Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)

PHASE3CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions

Asthma

Interventions

DRUG

Ciclesonide

Trial Locations (1)

SW3 6NP

"Altana Pharma/Nycomed", London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY